Uganda is among the 10 high-burden countries selected to benefit through the US President’s Emergency Plan for Aids Relief ...
AllAfrica on MSN
Uganda: U.S. Embassy Uganda Announces Introduction of Lenacapavir, a Groundbreaking HIV Prevention Medicine
Press Release - The U.S. Department of State announced a life-saving development to bring U.S.-based Gilead Sciences' breakthrough drug lenacapavir to market in Uganda, one of just ten high-burden HIV ...
allAfrica.com on MSN
New twice-a-year anti-HIV jab costs as much as daily prevention pill, set to launch by 2027
Two Indian generic drugmakers – Hetero and Dr Reddy’s – will be funded by the Gates Foundation and Unitaid, respectively, to ...
From 2027, Indian generics companies and Hetero Labs Dr. Reddy's will supply lenacapavir, a twice-yearly injectable PrEP with ~96-100% efficacy, for US$40 (R698) per person per year across 120 low- ...
In a year filled with global uncertainty, the 2025 Clinton Global Initiative (CGI), held last week in New York City, wrapped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback